Efficacy and safety of single-inhaler extrafine triple therapy versus inhaled corticosteroid plus long-acting beta2 agonist in eastern Asian patients with COPD: the TRIVERSYTI randomised controlled trial

被引：0
|
作者：
Jinping Zheng
Simonetta Baldi
Li Zhao
Huiping Li
Kwan-Ho Lee
Dave Singh
Alberto Papi
Frédérique Grapin
Alessandro Guasconi
George Georges
机构：
[1] First Affiliated Hospital of Guangzhou Medical University,State Key Laboratory of Respiratory Disease, National Clinical Research Centre for Respiratory Disease, Guangzhou Institute of Respiratory Health
[2] Chiesi Farmaceutici SpA,Global Clinical Development
[3] Shengjing Hospital of China Medical University,Medicines Evaluation Unit, The University of Manchester
[4] Shanghai Pulmonary Hospital,Respiratory Medicine Unit, University of Ferrara
[5] Yeungnam University Medical Center,undefined
[6] Manchester University NHS Foundations Trust,undefined
[7] University Hospital S. Anna,undefined
来源：
Respiratory Research | / 22卷
关键词：
Triple inhalation therapy; Chronic obstructive pulmonary disease; Chronic bronchitis; Airway obstruction; Extrafine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Efficacy and safety of single-inhaler extrafine triple therapy versus inhaled corticosteroid plus long-acting beta2 agonist in eastern Asian patients with COPD: the TRIVERSYTI randomised controlled trial
    Zheng, Jinping
    Baldi, Simonetta
    Zhao, Li
    Li, Huiping
    Lee, Kwan-Ho
    Singh, Dave
    Papi, Alberto
    Grapin, Frederique
    Guasconi, Alessandro
    Georges, George
    RESPIRATORY RESEARCH, 2021, 22 (01)
  • [2] Single-Inhaler Triple vs Long-Acting Beta2-Agonist-Inhaled Corticosteroid Therapy for COPD Comparative Safety in Real-World Clinical Practice
    Suissa, Samy
    Dell'Aniello, Sophie
    Ernst, Pierre
    CHEST, 2025, 167 (03) : 712 - 723
  • [3] Open-inhaler versus single-inhaler triple therapy (long-acting muscarinic antagonist, inhaled corticosteroid, and long-acting β2-agonist) in asthma patients: a narrative review
    Wechsler, Michael E.
    Oppenheimer, John J.
    JOURNAL OF ASTHMA, 2023, 60 (09) : 1633 - 1645
  • [4] THE IMPACT TRIAL: IS SINGLE-INHALER TRIPLE THERAPY (FF/UMEC/VI) COST-EFFECTIVE VERSUS DUAL THERAPY WITH INHALED CORTICOSTEROID PLUS LONG-ACTING BETA AGONIST (FF/VI) IN PATIENTS WITH COPD IN SPAIN?
    Paly, V
    Vallejo-Aparicio, L. A.
    Schroeder, M.
    Martin, A.
    Izquierdo Alonso, J. L.
    Riesco Miranda, J. A.
    Soler Cataluna, J. J.
    Risebrough, N.
    Abreu, C.
    Biswas, C.
    Ismaila, A. S.
    VALUE IN HEALTH, 2019, 22 : S877 - S877
  • [5] COST-EFFECTIVENESS OF A NEW SINGLE INHALER TRIPLE THERAPY VERSUS A DUAL INHALED CORTICOSTEROID PLUS LONG-ACTING BETA AGONIST IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN SPAIN
    Benjamin, N.
    Huerta, A.
    Biswas, C.
    Schroeder, M.
    Whalen, J.
    Izquierdo Alonso, J. L.
    Soler Cataluna, J. J.
    Riesco Miranda, J. A.
    Martin, A.
    Atienza, L.
    Ismaila, A.
    VALUE IN HEALTH, 2018, 21 : S3 - S3
  • [6] Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long-acting β-agonist inhaler therapy in asthma
    Perrin, Kyle
    Williams, Mathew
    Wijesinghe, Meme
    James, Kate
    Weatherall, Mark
    Beasley, Richard
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 126 (03) : 505 - 510
  • [7] Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial
    Singh, Dave
    Papi, Alberto
    Corradi, Massimo
    Pavlisova, Ilona
    Montagna, Isabella
    Francisco, Catherine
    Cohuet, Geraldine
    Vezzoli, Stefano
    Scuri, Mario
    Vestbo, Jorgen
    LANCET, 2016, 388 (10048): : 963 - 973
  • [8] Long-acting muscarinic antagonist plus long-acting beta agonist versus long-acting beta agonist plus inhaled corticosteroid for COPD: A systematic review and meta-analysis
    Horita, Nobuyuki
    Miyazawa, Naoki
    Tomaru, Koji
    Inoue, Miyo
    Kaneko, Takeshi
    RESPIROLOGY, 2015, 20 (08) : 1153 - 1159
  • [9] Severe exacerbation and pneumonia in COPD patients treated with fixed combinations of inhaled corticosteroid and long-acting beta2 agonist
    Yang, Hsi-Hsing
    Lai, Chih-Cheng
    Wang, Ya-Hui
    Yang, Wei-Chih
    Wang, Cheng-Yi
    Wang, Hao-Chien
    Chen, Likwang
    Yu, Chong-Jen
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2017, 12 : 2477 - 2484
  • [10] Efficacy and safety of single-inhaler triple therapy of glycopyrronium, formoterol and fluticasone in patients with COPD: a double-blind, randomised controlled trial
    Salvi, Sundeep
    Balki, Akash
    Krishnamurthy, Srikanth
    Panchal, Sagar
    Patil, Saiprasad
    Kodgule, Rahul
    Khandagale, Hitesh
    Pendse, Amol
    Wu, Wen
    Rangwala, Shabbir
    Tandon, Monika
    Barkate, Hanmant
    ERJ OPEN RESEARCH, 2021, 7 (03)
12345